Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Shigellosis

Shigellosis

Part of Enterobacteriaceae Infections

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Shigellosis

7 trials tracked for Shigellosis: 1 in phase 3 or 4.

7Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 2 Phase 1 4
  1. Phase 3 Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel Completed
  2. Phase 2 Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection Completed
  3. Phase 2 Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a Completed
  4. Phase 1 Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults Completed
  5. Phase 1 Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Completed
  6. Phase 1 A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. Completed
Show 1 more trials
  1. Phase 1 Controlled Human Infection Model Challenge/Rechallenge Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Machine learning models predict ciprofloxacin resistance in Shigella isolates from Ontario
Infectious Disease
Machine learning models predict ciprofloxacin resistance in Shigella isolates from Ontario New Test Predicts Drug Failure Before It Starts
This primary research article evaluates machine learning models using k-mer features from whole-genome sequencing data to predict ciprofloxa…
A smart new computer program can tell doctors if a specific bug will ignore a common antibiotic, helping them pick a drug that actually work…
medRxiv Apr 16, 2026
Meta-analysis finds 9% Shigella prevalence across human, animal, food, and environmental samples in Cameroon
Infectious Disease Meta-analysis
Meta-analysis finds 9% Shigella prevalence across human, animal, food, and environmental samples in Cameroon Why a Common Diarrhea Bug in Cameroon Is Outsmarting First-Line Antibiotics
A systematic review and meta-analysis of 24,847 samples from Cameroon found an overall pooled Shigella prevalence of 9% (95% CI, 5.51%-14.76…
A Cameroon-wide review found Shigella infections cause about 6% of human diarrhea cases — and that the bacteria are increasingly resistant t…
Apr 13, 2026
Foodborne infection surveillance shows stable Listeria, Salmonella, Shigella rates, increase in other pathogens
Infectious Disease
Foodborne infection surveillance shows stable Listeria, Salmonella, Shigella rates, increase in other pathogens Foodborne illness surveillance shows mixed trends for different bacteria in 2019
A surveillance report from 10 U.S. sites found incidence of infections caused by Listeria, Salmonella, and Shigella remained unchanged, whil…
In 2019, foodborne infections from most tracked bacteria rose, while cases of Listeria, Salmonella, and Shigella stayed steady.
CDC Apr 6, 2026